D. Campagnolo

发表

Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity1

F. Shi, W. Piao, Y. Kuo, 2009, The Journal of Immunology.

Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy

D. Campagnolo, S. Belachew, M. Subramanyam, 2014, Annals of neurology.

Effect of timing of stabilization on length of stay and medical complications following spinal cord injury.

D. Campagnolo, R. E. Esquieres, K. Kopacz, 1997, The journal of spinal cord medicine.

T-bet deficiency decreases susceptibility to experimental myasthenia gravis

F. Shi, D. Campagnolo, J. Hao, 2009, Experimental Neurology.

Appropriateness Of The Ilfeld Psychiatric Symptom Index As A Screening Tool For Depressive Symptomatology In Persons With Spinal Cord Injury

R. Filart, D. Campagnolo, S. Millis, 2002, The journal of spinal cord medicine.

Mandatory clerkship in physical medicine and rehabilitation: effect on medical students' knowledge of physiatry.

J. Delisa, D. Campagnolo, S. Kirshblum, 1998, Archives of physical medicine and rehabilitation.

Differences in Bladder Care for Veterans with Multiple Sclerosis by Treatment Location

R. Marrie, G. Cutter, D. Campagnolo, 2009 .

SELECTING A PHYSICAL MEDICINE AND REHABILITATION RESIDENCY

J. Delisa, D. Campagnolo, S. Jain, 1992, American journal of physical medicine & rehabilitation.

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

S. Galetta, D. Campagnolo, R. Fox, 2021, Advances in Therapy.

Influence of Neurological Level on Immune Function Following Spinal Cord Injury: A Review

D. Campagnolo, S. Keller, J. A. Bartlett, 2000, The journal of spinal cord medicine.

Cooperation of Invariant NKT Cells and CD4+CD25+ T Regulatory Cells in the Prevention of Autoimmune Myasthenia1

P. Christadoss, F. Shi, A. La Cava, 2005, The Journal of Immunology.

Comparison of the Revised 2000 American Spinal Injury Association Classification Standards with the 1996 Guidelines

D. Campagnolo, S. Kirshblum, S. Millis, 2002, American journal of physical medicine & rehabilitation.

Demyelinating disease and polyvalent human papilloma virus vaccination

D. Campagnolo, T. Vollmer, R. Bomprezzi, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Degeneration in Autoimmune Disease Autoreactive T Cells Mediate NK Cell

F. Shi, D. Campagnolo, T. Vollmer, 2006 .

CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.

F. Shi, W. Piao, D. Campagnolo, 2007, Clinical immunology.

Therapeutic Effect of Anthracene-Based Anticancer Agent Ethonafide in an Animal Model of Multiple Sclerosis1

F. Shi, W. Piao, D. Campagnolo, 2007, The Journal of Immunology.

Model of Multiple Sclerosis Anticancer Agent Ethonafide in an Animal Therapeutic Effect of Anthracene-Based and

F. Shi, W. Piao, D. Campagnolo, 2007 .

Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?

F. Shi, D. Campagnolo, T. Vollmer, 2006, International immunology.

Adrenal and pituitary hormone patterns after spinal cord injury.

D. Campagnolo, S. Keller, J. A. Bartlett, 1999, American journal of physical medicine & rehabilitation.

LIFE SATISFACTION OF INDIVIDUALS WITH DUCHENNE MUSCULAR DYSTROPHY USING LONG-TERM MECHANICAL VENTILATORY SUPPORT

J. Bach, D. Campagnolo, S. Hoeman, 1991, American journal of physical medicine & rehabilitation.

Impaired phagocytosis of Staphylococcus aureus in complete tetraplegics.

D. Campagnolo, S. Keller, J. A. Bartlett, 1997, American journal of physical medicine & rehabilitation.

Validation of NARCOMS Depression Scale

R. Marrie, G. Cutter, D. Campagnolo, 2008 .

The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis

R. Marrie, D. Campagnolo, F. Foley, 2014, Multiple sclerosis.

Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia

P. Christadoss, F. Shi, A. La Cava, 2006, The Journal of Immunology.

Disparities in the management of multiple sclerosis–related bladder symptoms

R. Marrie, G. Cutter, D. Campagnolo, 2007, Neurology.

Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE

X. Montalban, L. Kappos, H. Hartung, 2015, Journal of Neurology.

A Review of Cases of Neuromyelitis Optica

D. Campagnolo, T. Vollmer, R. Bomprezzi, 2011, The neurologist.

The Multiple Sclerosis Intimacy and Sexuality Questionnaire — re-validation and development of a 15-item version with a large US sample

R. Marrie, G. Cutter, D. Campagnolo, 2013, Multiple sclerosis.

Heterotopic ossification after total hip replacement.

D. Campagnolo, S. Kirshblum, Steven Kirshblum, 1994, Journal of back and musculoskeletal rehabilitation.

Comorbidity delays diagnosis and increases disability at diagnosis in MS

R. Marrie, G. Cutter, R. Horwitz, 2009, Neurology.

Interleukin‐2/interleukin‐2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation

F. Shi, A. La Cava, W. Piao, 2011, Annals of neurology.

Improving Resident Research In Physical Medicine and Rehabilitation: Impact of A Structured Training Program

J. Delisa, D. Campagnolo, E. Elovic, 2004, The journal of spinal cord medicine.

ALTERATION OF IMMUNE SYSTEM FUNCTION IN TETRAPLEGICS: A Pilot Study

J. Delisa, D. Campagnolo, M. Sipski, 1994, American journal of physical medicine & rehabilitation.

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?

D. Arnold, A. Bar-Or, J. Oger, 2009, Multiple sclerosis.

High frequency of adverse health behaviors in multiple sclerosis

R. Marrie, G. Cutter, R. Horwitz, 2009, Multiple sclerosis.

Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease1

F. Shi, D. Campagnolo, T. Vollmer, 2006, The Journal of Immunology.

Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology

F. Shi, A. La Cava, W. Piao, 2010, The Journal of experimental medicine.

B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis

F. Shi, W. Piao, D. Campagnolo, 2010, Experimental Neurology.

CCL2 recruitment of IL‐6‐producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17‐dependent B cell‐mediated autoimmunity

F. Shi, R. Ransohoff, A. La Cava, 2008, European journal of immunology.

Smoking Status over Two Years in Patients with Multiple Sclerosis

R. Marrie, G. Cutter, D. Campagnolo, 2008, Neuroepidemiology.

Comorbidity, socioeconomic status and multiple sclerosis

G Cutter, R. Marrie, G. Cutter, 2008, Multiple sclerosis.

Computed tomography--guided aspiration of a ganglion cyst of the anterior cruciate ligament: a case report.

D. Campagnolo, M. Blacksin, B. Davis, 1996, Archives of physical medicine and rehabilitation.

Psychosocial adjustment of post-poliomyelitis ventilator assisted individuals.

J. Bach, D. Campagnolo, 1992, Archives of physical medicine and rehabilitation.

Critical Review of Prolotherapy for Osteoarthritis, Low Back Pain, and other Musculoskeletal Conditions: A Physiatric Perspective

B. Greenwald, D. Campagnolo, T. Stitik, 2004, American journal of physical medicine & rehabilitation.

Silent autonomic dysreflexia during voiding in men with spinal cord injuries.

D. Campagnolo, T. Linsenmeyer, I. Chou, 1996, The Journal of urology.

IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis

F. Shi, D. Campagnolo, T. Vollmer, 2008, Experimental Neurology.

Prevalence of urinary incontinence after brain injury.

D. Campagnolo, T. Linsenmeyer, A. Averill, 1994, NeuroRehabilitation.

Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.

D. Arnold, L. Weiner, A. Bar-Or, 2007, Archives of neurology.

High-dose methylprednisolone may do more harm for spinal cord injury.

D. Campagnolo, S. Kirshblum, T. Qian, 2000, Medical hypotheses.

Practice and career satisfaction among physiatrists. A national survey.

J. Delisa, M. Johnston, T. Findley, 1997, American journal of physical medicine & rehabilitation.

Spinal Cord Medicine

Steven Kirshblum, Mark S. Nash, M. Nash, 2001 .

FACTORS USED BY PHYSICAL MEDICINE AND REHABILITATION RESIDENCY TRAINING DIRECTORS TO SELECT THEIR RESIDENTS

D. Campagnolo, S. Jain, Joel A. DeLisa, 1994, American journal of physical medicine & rehabilitation.

Nicotine and inflammatory neurological disorders

F. Shi, W. Piao, D. Campagnolo, 2009, Acta Pharmacologica Sinica.

Technique for studying conduction in the lateral cutaneous nerve of calf

J. Delisa, D. Campagnolo, P. Foye, 2000, Muscle & nerve.

CHIEF RESIDENTS IN PHYSIATRY: Expectations v Training

D. Campagnolo, S. Jain, Joel A. DeLisa, 1993, American journal of physical medicine & rehabilitation.

FACTORS INFLUENCING THE SPECIALTY CHOICE OF THE PHYSICAL MEDICINE AND REHABILITATION GRADUATING CLASS OF 1994 AND THE ENTERING CLASS OF 1995

D. Campagnolo, S. Kirshblum, S. Jain, 1995, American journal of physical medicine & rehabilitation.

A METHOD TO ASSESS THE TRAINEE PROFILES OF MEDICAL STUDENTS ATTRACTED TO OUR PHYSICAL MEDICINE AND REHABILITATION RESIDENCY TRAINING PROGRAM

J. Delisa, D. Campagnolo, P. McCutcheon, 1993, American journal of physical medicine & rehabilitation.

Chief residents in physiatry. Expectations v training.

J. Delisa, D. Campagnolo, S. Jain, 1993 .

APOE &egr;4 Is Associated With Exacerbation of Cognitive Decline in Patients With Multiple Sclerosis

L. Baxter, D. Campagnolo, T. Vollmer, 2011, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Validation of the NARCOMS registry: diagnosis

R. Marrie, G. Cutter, D. Campagnolo, 2007, Multiple sclerosis.

Does multiple sclerosis–associated disability differ between races?

R. Marrie, G. Cutter, D. Campagnolo, 2006, Neurology.

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

R. Marrie, R. Rudick, G. Cutter, 2010, Neurology.

The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated

R. Marrie, G. Cutter, R. Horwitz, 2009, Multiple sclerosis.

Analyzing Chronic Diseases with Latent Growth Models: An Analysis of Multiple Sclerosis

Ajay S. Vinze, T. S. Raghu, Ronald D. Freeze, 2009, 2009 42nd Hawaii International Conference on System Sciences.

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

D. Arnold, A. Bar-Or, M. Freedman, 2008, Multiple sclerosis.

Expansion of regulatory T cells via IL‐2/anti‐IL‐2 mAb complexes suppresses experimental myasthenia

F. Shi, A. La Cava, D. Campagnolo, 2010, European journal of immunology.

Changes in the ascertainment of multiple sclerosis

R. Marrie, G. Cutter, D. Campagnolo, 2005, Neurology.

Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies: A NARCOMS Analysis.

D. Campagnolo, R. Fox, A. Salter, 2016, International journal of MS care.

Validation of the NARCOMS Registry: fatigue assessment

R. Marrie, G. Cutter, D. Campagnolo, 2005, Multiple sclerosis.

Altered innate immunity following spinal cord injury

D. Campagnolo, Diego Campagnolo, S. Keller, 2008, Spinal Cord.

High lumbar disc: diagnostic and treatment dilemma.

D. Campagnolo, T. Stitik, S. Nadler, 1998, American journal of physical medicine & rehabilitation.

Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.

D. Campagnolo, R. Fox, A. Salter, 2013, International journal of MS care.

Measuring up rates for adverse health behaviors in multiple sclerosis: the need for action

G. Cutter, R. Horwitz, D. Campagnolo, 2009 .

Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS

Deborah M. Miller, R. Rudick, T. Ziemssen, 2021, Multiple sclerosis journal - experimental, translational and clinical.

Inflammatory Demyelinating Diseases of the Central Nervous System

D. Campagnolo, R. Bomprezzi, 2009 .

Effect of physical comorbidities on risk of depression in Multiple Sclerosis

R. Marrie, G. Cutter, D. Campagnolo, 2013 .

Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay

D. Campagnolo, H. Koendgen, Q. Dong, 2016, Journal of NeuroVirology.

Sa.19. Autoreactive T-Cells Mediate NK Cell Degeneration in Autoimmune Disease

F. Shi, D. Campagnolo, T. Vollmer, 2006 .

Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial

D. Arnold, L. Weiner, A. Bar-Or, 2007 .

IL‐21 Modulates CD4+ CD25+ Regulatory T‐Cell Homeostasis in Experimental Autoimmune Encephalomyelitis

S. Coons, F. Shi, A. La Cava, 2007, Scandinavian journal of immunology.

Comorbidity delays diagnosis and increases disability at diagnosis in MS

R. Marrie, R. Horwitz, D. Campagnolo, 2009, Neurology.

North American Research Committee on Multiple Sclerosis

D. Campagnolo, 2006 .

Critical evaluation of clinical research.

J Whyte, Z M Pine, J. Whyte, 1995, Archives of physical medicine and rehabilitation.

The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis

R. Marrie, D. Campagnolo, F. Foley, 2014, Multiple sclerosis.

The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated

R. Marrie, R. Horwitz, D. Campagnolo, 2009, Multiple sclerosis.